Smith & Nephew - SN Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 1,408.60
  • Forecasted Upside: 25.94%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1,118.50
▼ -3.5 (-0.31%)

This chart shows the closing price for SN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Smith & Nephew Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SN

Analyst Price Target is GBX 1,408.60
▲ +25.94% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Smith & Nephew in the last 3 months. The average price target is GBX 1,408.60, with a high forecast of GBX 1,500 and a low forecast of GBX 1,243. The average price target represents a 25.94% upside from the last price of GBX 1,118.50.

This chart shows the closing price for SN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 contributing investment analysts is to buy stock in Smith & Nephew. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/8/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/6/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/4/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/3/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/1/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/31/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/17/2022Berenberg BankReiterated RatingBuyGBX 1,400
11/9/2022Berenberg BankReiterated RatingBuy
11/7/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,500
11/4/2022BarclaysLower TargetOverweightGBX 1,530 ➝ GBX 1,500
10/27/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,500
10/4/2022BarclaysLower TargetOverweightGBX 1,550 ➝ GBX 1,530
9/13/2022Royal Bank of CanadaReiterated RatingSector PerformGBX 1,500
9/8/2022Berenberg BankLower TargetBuyGBX 1,800 ➝ GBX 1,400
8/4/2022JPMorgan Chase & Co.Lower TargetNeutralGBX 1,442 ➝ GBX 1,243
8/4/2022Credit Suisse GroupLower TargetOutperformGBX 1,540 ➝ GBX 1,400
8/4/2022BarclaysLower TargetOverweightGBX 1,630 ➝ GBX 1,550
7/26/2022Berenberg BankLower TargetBuyGBX 1,825 ➝ GBX 1,490
7/21/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,700
7/14/2022Berenberg BankReiterated RatingBuyGBX 1,800
7/4/2022BarclaysLower TargetOverweightGBX 1,650 ➝ GBX 1,630
7/1/2022JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,442
5/31/2022BarclaysLower TargetOverweightGBX 1,680 ➝ GBX 1,650
5/4/2022Berenberg BankLower TargetBuyGBX 1,840 ➝ GBX 1,800
5/4/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,700
4/5/2022BarclaysBoost TargetOverweightGBX 1,670 ➝ GBX 1,680
4/1/2022JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,442
3/24/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,700
3/15/2022Royal Bank of CanadaInitiated CoverageOutperformGBX 1,700
3/3/2022Berenberg BankReiterated RatingBuyGBX 1,840
2/24/2022BarclaysLower TargetOverweightGBX 1,685 ➝ GBX 1,670
2/9/2022BarclaysLower TargetEqual WeightGBX 1,700 ➝ GBX 1,685
2/8/2022JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,376
1/31/2022JPMorgan Chase & Co.Lower TargetNeutralGBX 1,379 ➝ GBX 1,376
1/13/2022JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,379
1/4/2022JPMorgan Chase & Co.Reiterated RatingNeutral
12/17/2021Berenberg BankBoost TargetBuyGBX 1,825 ➝ GBX 1,840
12/9/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,379
11/10/2021BarclaysReiterated RatingOverweightGBX 1,760
11/5/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,379
11/4/2021Berenberg BankLower TargetBuyGBX 1,880 ➝ GBX 1,825
11/4/2021Shore CapitalReiterated RatingHold
10/5/2021BarclaysLower TargetOverweightGBX 1,775 ➝ GBX 1,760
10/4/2021Berenberg BankLower TargetBuyGBX 2,020 ➝ GBX 1,880
9/10/2021BarclaysLower TargetOverweightGBX 1,825 ➝ GBX 1,800
8/2/2021JPMorgan Chase & Co.Boost TargetNeutralGBX 1,542 ➝ GBX 1,579
7/29/2021Shore CapitalReiterated RatingHold
7/16/2021Berenberg BankReiterated RatingBuyGBX 2,020
7/1/2021BarclaysBoost TargetOverweightGBX 1,800 ➝ GBX 1,825
6/9/2021Credit Suisse GroupUpgradeOutperformGBX 1,560 ➝ GBX 1,805
5/18/2021Shore CapitalReiterated RatingHold
4/29/2021Shore CapitalReiterated RatingHold
4/20/2021Berenberg BankReiterated RatingBuyGBX 1,985
3/2/2021Shore CapitalReiterated RatingHold
2/23/2021JPMorgan Chase & Co.Lower TargetNeutralGBX 1,563 ➝ GBX 1,423
2/12/2021Berenberg BankReiterated RatingBuyGBX 2,005
1/21/2021BarclaysLower TargetOverweightGBX 1,900 ➝ GBX 1,875
1/12/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,438
11/2/2020Berenberg BankLower TargetBuyGBX 2,090 ➝ GBX 1,975
10/27/2020Shore CapitalReiterated RatingSell
7/30/2020Morgan StanleyLower TargetOverweightGBX 1,950 ➝ GBX 1,940
7/30/2020Berenberg BankLower TargetBuyGBX 2,150 ➝ GBX 2,090
7/30/2020Credit Suisse GroupLower TargetNeutralGBX 1,685 ➝ GBX 1,675
7/30/2020JPMorgan Chase & Co.Lower TargetNeutralGBX 1,633 ➝ GBX 1,553
7/29/2020Shore CapitalReiterated RatingSell
7/22/2020Credit Suisse GroupReiterated RatingNeutral
7/20/2020JPMorgan Chase & Co.Reiterated RatingNeutral
7/10/2020Berenberg BankLower TargetBuyGBX 2,165 ➝ GBX 2,150
7/9/2020Morgan StanleyLower TargetBuyGBX 2,165 ➝ GBX 2,150
7/1/2020Shore CapitalReiterated RatingSell
6/23/2020UBS GroupReiterated RatingNeutral
6/18/2020CitigroupLower TargetNeutralGBX 1,700 ➝ GBX 1,670
6/4/2020Morgan StanleyUpgradeOverweightGBX 1,990 ➝ GBX 1,950
5/15/2020Credit Suisse GroupLower TargetNeutralGBX 1,825 ➝ GBX 1,685
5/7/2020Berenberg BankBoost TargetBuyGBX 2,135 ➝ GBX 2,165
5/7/2020JPMorgan Chase & Co.Lower TargetNeutralGBX 1,658 ➝ GBX 1,633
5/6/2020Shore CapitalReiterated RatingSell
4/28/2020Jefferies Financial GroupLower TargetBuyGBX 2,160 ➝ GBX 1,800
4/17/2020Berenberg BankReiterated RatingBuy
4/14/2020CitigroupDowngradeNeutralGBX 2,250 ➝ GBX 1,700
3/31/2020UBS GroupReiterated RatingNeutral
3/31/2020JPMorgan Chase & Co.Lower TargetNeutralGBX 1,926 ➝ GBX 1,658
3/30/2020Sanford C. BernsteinDowngradeMarket Perform
3/30/2020Shore CapitalReiterated RatingSell
3/26/2020Berenberg BankLower TargetBuyGBX 2,335 ➝ GBX 2,135
2/26/2020UBS GroupBoost TargetNeutralGBX 1,800 ➝ GBX 1,860
2/25/2020Berenberg BankBoost TargetBuyGBX 2,325 ➝ GBX 2,335
2/21/2020JPMorgan Chase & Co.Boost TargetNeutralGBX 1,711 ➝ GBX 1,926
2/20/2020Shore CapitalReiterated RatingSell
2/17/2020UBS GroupReiterated RatingNeutral
2/12/2020Berenberg BankBoost TargetBuyGBX 2,185 ➝ GBX 2,325
2/5/2020JPMorgan Chase & Co.Reiterated RatingNeutral
1/24/2020Shore CapitalReiterated RatingSell
1/21/2020Jefferies Financial GroupLower TargetBuyGBX 2,200 ➝ GBX 2,160
1/15/2020The Goldman Sachs GroupLower TargetNeutralGBX 1,695 ➝ GBX 1,670
12/5/2019Berenberg BankReiterated RatingBuy
11/21/2019CitigroupInitiated CoverageBuy
11/13/2019The Goldman Sachs GroupBoost TargetNeutralGBX 1,685 ➝ GBX 1,695
11/8/2019Shore CapitalReiterated RatingSell
11/4/2019JPMorgan Chase & Co.Lower TargetNeutralGBX 1,814 ➝ GBX 1,711
11/4/2019Credit Suisse GroupLower TargetNeutralGBX 1,770 ➝ GBX 1,725
11/1/2019Berenberg BankLower TargetBuyGBX 2,185
10/31/2019Shore CapitalReiterated RatingSell
10/28/2019UBS GroupReiterated RatingNeutralGBX 1,830 ➝ GBX 1,800
10/21/2019Berenberg BankReiterated RatingBuyGBX 2,250
10/21/2019Shore CapitalReiterated RatingSell
10/4/2019Berenberg BankLower TargetBuyGBX 2,250
8/6/2019UBS GroupBoost TargetNeutralGBX 1,730 ➝ GBX 1,830
7/31/2019Shore CapitalReiterated RatingSell
7/29/2019UBS GroupReiterated RatingNeutral
7/22/2019UBS GroupBoost TargetNeutralGBX 1,455 ➝ GBX 1,730
7/12/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
6/10/2019Shore CapitalDowngradeSell
5/9/2019JPMorgan Chase & Co.Boost TargetNeutralGBX 1,689 ➝ GBX 1,758
5/2/2019UBS GroupReiterated RatingNeutralGBX 1,455
4/26/2019Berenberg BankReiterated RatingHoldGBX 1,475
4/25/2019Credit Suisse GroupReiterated RatingNeutral
3/14/2019UBS GroupReiterated RatingNeutral
2/11/2019JPMorgan Chase & Co.Boost TargetNeutralGBX 1,477 ➝ GBX 1,516
2/11/2019The Goldman Sachs GroupBoost TargetNeutralGBX 1,400 ➝ GBX 1,440
2/8/2019BNP ParibasDowngradeNeutralGBX 1,475 ➝ GBX 1,525
2/8/2019Credit Suisse GroupBoost TargetNeutralGBX 1,330 ➝ GBX 1,390
2/8/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
1/28/2019UBS GroupBoost TargetNeutralGBX 1,340 ➝ GBX 1,390
1/8/2019JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,477
1/2/2019JPMorgan Chase & Co.DowngradeNeutralGBX 1,477
12/10/2018Morgan StanleyUpgradeOverweightGBX 1,457 ➝ GBX 1,692
12/10/2018Deutsche Bank AktiengesellschaftUpgradeHoldGBX 1,200 ➝ GBX 1,350
11/2/2018Berenberg BankBoost TargetHoldGBX 1,370 ➝ GBX 1,475
10/26/2018UBS GroupReiterated RatingNeutral
10/16/2018HSBCDowngradeHoldGBX 1,400 ➝ GBX 1,500
10/5/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
8/8/2018UBS GroupDowngradeNeutralGBX 1,470 ➝ GBX 1,340
7/30/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
7/26/2018Numis SecuritiesBoost TargetAddGBX 1,350 ➝ GBX 1,480
7/20/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
7/3/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
5/14/2018Berenberg BankReiterated RatingHoldGBX 1,370
5/8/2018UBS GroupLower TargetBuyGBX 1,550 ➝ GBX 1,470
5/4/2018Deutsche Bank AktiengesellschaftDowngradeSell
5/3/2018Jefferies Financial GroupReiterated RatingBuyGBX 1,515
4/25/2018JPMorgan Chase & Co.Reiterated RatingOverweight
4/24/2018Credit Suisse GroupReiterated RatingNeutralGBX 1,290
4/17/2018Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,315 ➝ GBX 1,309.50
4/12/2018Jefferies Financial GroupReiterated RatingBuy
4/5/2018JPMorgan Chase & Co.Boost TargetOverweightGBX 1,411 ➝ GBX 1,463
3/26/2018HSBCUpgradeBuyGBX 1,320 ➝ GBX 1,530
2/13/2018Morgan StanleyLower TargetEqual weightGBX 1,558 ➝ GBX 1,457
2/9/2018Credit Suisse GroupBoost TargetNeutralGBX 1,285 ➝ GBX 1,290
2/7/2018JPMorgan Chase & Co.Reiterated RatingOverweightGBX 1,411
2/1/2018JPMorgan Chase & Co.Reiterated RatingOverweightGBX 1,411
(Data available from 1/31/2018 forward)

News Sentiment Rating

0.06 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/4/2022
  • 4 very positive mentions
  • 1 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
8/3/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/2/2022
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/2/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/1/2022
  • 3 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/1/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/31/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/30/2023

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Negative

  • No negative mentions tracked during this time.

Very Positive

Smith & Nephew logo
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Read More

Today's Range

Now: GBX 1,118.50
Low: 1,115
High: 1,127.76

50 Day Range

MA: GBX 1,113.79
Low: 1,071
High: 1,182.50

52 Week Range

Now: GBX 1,118.50
Low: 959.20
High: 1,357.50

Volume

1,720,306 shs

Average Volume

343,671 shs

Market Capitalization

£9.74 billion

P/E Ratio

2,431.52

Dividend Yield

2.85%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Smith & Nephew?

The following sell-side analysts have issued reports on Smith & Nephew in the last year: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, JPMorgan Chase & Co., and Royal Bank of Canada.
View the latest analyst ratings for SN.

What is the current price target for Smith & Nephew?

5 Wall Street analysts have set twelve-month price targets for Smith & Nephew in the last year. Their average twelve-month price target is GBX 1,408.60, suggesting a possible upside of 25.5%. Barclays PLC has the highest price target set, predicting SN will reach GBX 1,500 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of GBX 1,243 for Smith & Nephew in the next year.
View the latest price targets for SN.

What is the current consensus analyst rating for Smith & Nephew?

Smith & Nephew currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SN will outperform the market and that investors should add to their positions of Smith & Nephew.
View the latest ratings for SN.

What other companies compete with Smith & Nephew?

How do I contact Smith & Nephew's investor relations team?

Smith & Nephew's physical mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company's listed phone number is +44-20-74017646. The official website for Smith & Nephew is www.smith-nephew.com. Learn More about contacing Smith & Nephew investor relations.